WT1 was expressed by three out of ten adult B-ALL patients (Figure 2B) however the median ΔCT of B-ALL patients and normal controls, 12.88 and 12.81 respectively, were almost equal. This evidence concerns the gene WT1 and precursor B-cell acute lymphoblastic leukemia.